ARIE: A Health Equity Framework for Public Health Interventions Informed by Critical Race Theory and Critical Gerontology.

Older racialized minorities were particularly vulnerable during the last pandemic due to the interlocking influences of structural racism and ageism, which are often disregarded in public health planning. This oversight not only compromises the social justice and health equity goals of public health efforts but it also calls for a more inclusive approach that systematically addresses these deficiencies at every stage of a public health response. To achieve this, we propose (ARIE), a novel analytical framework grounded in critical race theory and critical gerontology.

A scientometric analysis of fairness in health AI literature.

Artificial intelligence (AI) and machine learning are central components of today's medical environment. The fairness of AI, i.e.

When citizen science is public relations.

Amid rising interest in participatory research, some industries have recently begun to practice (PRCS). Unlike citizen science and crowdsourcing projects that generate raw materials for product development, PRCS benefits capitalist firms primarily by improving their public image and deflecting accusations of causing harm. Three cases illustrate how PRCS works: (1) a growing assortment of citizen science projects associated with Antarctic tourism, (2) an initiative to document biodiversity, linked to Canada's oil and gas industry, and (3) a study sponsored by Biology Fortified, a nonprofit organization that works to communicate positive information about agricultural biotechnology.

Which patients benefit from preoperative biliary drainage in resectable pancreatic cancer?

Recent studies have indicated that preoperative biliary drainage (PBD) should not be routinely performed in all patients suffering from obstructive jaundice before pancreatic surgery. The severity of jaundice that mandates PBD has yet to be defined. The evaluated paper examines the impact of PBD on intra-operative, and post-operative outcomes in patients initially presenting with severe obstructive jaundice (bilirubin ≥250 μmol/L).